{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:05:48Z","timestamp":1792037148328,"version":"4.4.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s30139","type":"journal-article","created":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T16:13:36Z","timestamp":1340381616000},"page":"323","source":"Crossref","is-referenced-by-count":66,"title":["Interest in paromomycin for the treatment of visceral leishmaniasis (kala-azar)"],"prefix":"10.2147","author":[{"given":"Viroj","family":"Wiwanitkit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2012,6]]},"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=13071","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:18:51Z","timestamp":1477865931000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/interest-in-paromomycin-for-the-treatment-of-visceral-leishmaniasis-ka-peer-reviewed-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/tcrm.s30139","relation":{},"ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}